Huge cuts at Schering-Plough: 1,000 sales jobs going away – As part of a reorganization already under way, the drugmaker is eliminating 1,000 sales jobs – or 20 percent of its sales force – by October. Many of the 4,000 or so surviving reps, meanwhile, will be shifted to pitch different types of docs or work in other territories. A Schering-Plough spokesman confirmed the cuts…more
New Roche arthritis biologic delayed – In a setback for the drugmaker, the agency has issued a ‘complete response’ letter for Actemra, a biologic Roche hopes to market for treating rheumatoid arthritis. An FDA advisory committee endorsed its use last July by a 10-1 vote, but the agency wants “additional documentation” about manufacturing and other unspecified info, some of which relates to final labeling, according to Roche…more
Merck’s Gardasil: OK for vaginal cancer – U.S. health regulators have approved Merck and Co’s Gardasil vaccine to protect women against rare vaginal and vulvar cancers, the Food and Drug Administration said on Friday…more
GSK’s Tykerb: OK for head and neck cancer (maybe) – New clinical data supports the use of GlaxoSmithKline’s drug Tykerb as a treatment for head and neck cancer, endorsing the company’s move to push ahead with a final Phase III study in this indication…more
UCB’s Keppra XR: OK for sale – Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent protection…more
Impactiviti’s Recommendra: Now prescribed for all training recommendations (OK, just checking to see if you were reading…)
J&J putting some heat on Enbrel for psoriasis – Johnson & Johnson said on Thursday its experimental psoriasis drug proved more effective than top-selling treatment Enbrel in a late-stage trial, was just as safe and required far fewer injections…more
Memory Pharmaceuticals – forget about jobs for half of employees.
An interesting new avenue of diabetes research unveiled – new class of hormones produced by body fat identified.
On the pharma marketing front….
Reuters and The Doctor’s Channel collaborate for streaming video healthcare “snacking.”